Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropicamide 0.5% versus 1% effects on intraocular pressure in adults with diabetes
IRCT20200829048553N1Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tropicamide in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Intraocular pressure and Pupil diameter. Started Jul 2021; status: completed.
02
Drugs
tropicamide
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20200829048553N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200829048553N1.